Kimoon Nam
CEO @ Smilegate Investment
Seongnam, South Korea
Kimoon Nam is a seed investor at Smilegate Investment in Seongnam focused on Fashion and Health Care. Kimoon Nam - CEO @ Smilegate Investment
- Total investments:
- 2
- Last investment:
- Lead investor:
- 50%
Last updated:
For AI agents: llms.txt
Industries Kimoon Nam invests in
Stages Kimoon Nam invests in
Countries Kimoon Nam invests in
Contacts
| Type | Contact | Validation |
|---|---|---|
| Work email | ||
| Personal email | ||
| Work phone | ||
| Personal phone | ||
| Socials |
Investment Focus
Industry
- Fashion 1 (50%)
- Health Care 1 (50%)
- Biotechnology 1 (50%)
- Manufacturing 1 (50%)
- Medical Device 1 (50%)
Stage
- Seed 1 (50%)
- Series B 1 (50%)
Country
- South Korea 1 (50%)
- United States 1 (50%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| TAU is developing state-of-the-art minimally invasive catheter-based surgical methodologies for treating structural heart diseases like Tricuspid Valve Regurgitation (TR), Mitral Valve Regurgitation (MR), Hypertrophic Obstructive Cardiomyopathy (HOCM), and Heart arrhythmia. | $22M / Series B / Jul 09, 2020 | ||
| Stripes is a Korea-based apparel company that designs and manufactures men’s clothing products. Stripes’ clothing collection carries directional designs, as well as every day favorites including, t-shirts, shirts, and suits. The company also provides personalized styling services, enabling customers to personalize their clothes and have themdesigned to a perfect fit. Stripes markets its product through the web and mobile medium, giving consumers the facility of buying clothes at the comfort of their homes.Stripes was established in January 2013. | $1M / Seed / Oct 24, 2014 |
Co-Investors
About Smilegate Investment
Smilegate Investment, founded in 1999 originally as MVP Capital, is a venture capital and private equity firm that grows remarkably alongside invested companies. Since initial venture capital funding in 2000, the firm has since organized and managed more than 30 venture capital and private equity funds and has invested in more than 200 companieswith promising growth potential.
Smilegate Investment Contacts
| Name | Phone | Socials | |
|---|---|---|---|
|
Hoon-gon Nam
Senior Manager
|
|||
Insoo Paik
Principal
|
|||
Inwoo Kang
General Manager
|
|||
Jong Hyuk Park
Executive Vice President
|
|||
|
Kimoon Nam
CEO
|
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Recommended lists
FAQ
What does Kimoon Nam invest in?
Kimoon Nam invests primarily in Fashion, Health Care and Biotechnology startups, most often at Seed and Series B stage. Most of the 2 investments tracked by Shizune back companies in South Korea. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Kimoon Nam?
Public channels for Kimoon Nam include LinkedIn. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
When did Kimoon Nam last invest?
The most recent investment recorded for Kimoon Nam closed in Jul 2020. Shizune tracks 2 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Sep 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
